Gene · 5154
Papers4,148
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
741 to 760 of 4,148
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Advances in pediatric non-alcoholic fatty liver disease: From genetics to lipidomics. | World J Clin Pediatr | 2022 | 35663007 | PubTator, text mining | PubMed |
| Recurrent noncoding somatic and germline WT1 variants converge to disrupt MYB binding in acute promyelocytic leukemia. | Blood | 2022 | 35653587 | PubTator, text mining | PubMed |
| The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials. | Front Bioeng Biotechnol | 2022 | 35646879 | PubTator, text mining | PubMed |
| RNA Sequencing Reveals Alterations and Similarities in Cell Metabolism, Hypoxia and Immune Evasion in Primary Cell Cultures of Clear Cell Renal Cell Carcinoma. | Front Oncol | 2022 | 35646693 | PubTator, text mining | PubMed |
| High-Throughput Sequencing to Investigate lncRNA-circRNA-miRNA-mRNA Networks Underlying the Effects of Beta-Amyloid Peptide and Senescence on Astrocytes. | Front Genet | 2022 | 35646066 | PubTator, text mining | PubMed |
| The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target? | Life (Basel) | 2022 | 35629326 | PubTator, text mining | PubMed |
| Epigenetic Silencing of PTEN and Epi-Transcriptional Silencing of MDM2 Underlied Progression to Secondary Acute Myeloid Leukemia in Myelodysplastic Syndrome Treated with Hypomethylating Agents. | Int J Mol Sci | 2022 | 35628480 | PubTator, text mining | PubMed |
| The Role of MiR-181 Family Members in Endothelial Cell Dysfunction and Tumor Angiogenesis. | Cells | 2022 | 35626707 | PubTator, text mining | PubMed |
| Expression Profile of mRNAs and miRNAs Related to the Oxidative-Stress Phenomenon in the Ishikawa Cell Line Treated Either Cisplatin or Salinomycin. | Biomedicines | 2022 | 35625926 | PubTator, text mining | PubMed |
| Biomarkers as Predictive Factors of Anti-VEGF Response. | Biomedicines | 2022 | 35625740 | PubTator, text mining | PubMed |
| OGG1 in Lung-More than Base Excision Repair. | Antioxidants (Basel) | 2022 | 35624797 | PubTator, text mining | PubMed |
| Intranasal Administration of Nanovectorized Docosahexaenoic Acid (DHA) Improves Cognitive Function in Two Complementary Mouse Models of Alzheimer's Disease. | Antioxidants (Basel) | 2022 | 35624701 | PubTator, text mining | PubMed |
| Platelet-Related Molecular Subtype to Predict Prognosis in Hepatocellular Carcinoma. | J Hepatocell Carcinoma | 2022 | 35615530 | PubTator, text mining | PubMed |
| Cancer-associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications. | Int J Cancer | 2022 | 35603909 | PubTator, text mining | PubMed |
| Inflammation-Related Epigenetic Modification: The Bridge Between Immune and Metabolism in Type 2 Diabetes. | Front Immunol | 2022 | 35603204 | PubTator, text mining | PubMed |
| Sprouting Angiogenesis in Human Pituitary Adenomas. | Front Oncol | 2022 | 35600354 | PubTator, text mining | PubMed |
| Novel approach to antiangiogenic factors in age-related macular degeneration therapy. | Cent Eur J Immunol | 2022 | 35600160 | PubTator, text mining | PubMed |
| Fluorescence in situ hybridization detection of chromosome 7 and/or 17 polysomy as a prognostic marker for cholangiocarcinoma. | Sci Rep | 2022 | 35589822 | PubTator, text mining | PubMed |
| Conditioned Medium from Human Uterine Cervical Stem Cells Regulates Oxidative Stress and Angiogenesis of Retinal Pigment Epithelial Cells. | Ophthalmic Res | 2022 | 35584686 | PubTator, text mining | PubMed |
| Dynamic Interplay between Structural Variations and 3D Genome Organization in Pancreatic Cancer. | Adv Sci (Weinh) | 2022 | 35570408 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/5154/papers?page=38